Bio-Rad Laboratories | BIO - Zahlungsmittel Und Äquivalente

Aktienkurs
269.47
Täglich Wechseln
-0.01 -0.004%
Monatlich
-0.89%
Jährlich
6.20%
Q1 Prognose
254.86




Zahlungsmittel Und Äquivalente Veränderung Datum
Abbott USD 8.52B 1.01B 2025-12
Agilent USD 1.76B 31M 2025-12
Becton, Dickinson and Co. USD 740M 99M 2025-12
Bio Techne USD 172.88M 27.92M 2025-12
Bio-Rad Laboratories USD 529.8M 134M 2025-12
Bruker USD 293.1M 201.1M 2025-09
Charles River Laboratories USD 213.77M 6.67M 2025-12
Danaher USD 4.62B 3.09B 2025-12
Exact Sciences USD 956M 166.96M 2025-12
General Electric Aerospace USD 12.39B 109M 2025-12
Hologic USD 2.17B 208.5M 2025-12
Illumina USD 1.42B 368M 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Laboratory Of America USD 532.3M 65.8M 2025-12
Merck USD 18.17B 10.16B 2025-09
Mettler Toledo International USD 69.06M 7.24M 2025-09
Myriad Genetics USD 145.4M 71M 2025-09
OraSure Technologies USD 199.28M 17.2M 2025-12
Pacific Biosciences Of California USD 279.51M 223.04M 2025-12
Quest Diagnostics USD 420M 12M 2025-12
Repligen USD 566.02M 182.73M 2025-12
Revvity USD 919.86M 11.53M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Siemens EUR 14.5B 146M 2025-09
Standard Biotools USD 129.42M 29.2M 2025-09
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Tosoh JPY 133.1B 10.44B 2025-09
Waters USD 587.83M 128.71M 2025-12